Skip to content
Wenlo
Sign in
← Markets

ResMed Inc.

ResMed Inc. (RMD) — Form 8-K: Current report

8-KRMDFiled Nov 19, 2026, 4:15 PM ET· Period Nov 18, 2026

AI-generated summary

ResMed Inc. reported on events from its annual meeting held on November 18, 2026, including the retirement of director Ronald Taylor and the reduction of the board size from eleven to ten directors. Shareholders elected ten directors, ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approved executive compensation on an advisory basis. Additionally, the company's compensation committee approved a new form of performance-based restricted stock unit award agreement for fiscal year 2027 grants to named executive officers.

Key facts

  • Item 5.02 · Executive or director change or pay arrangement
  • Item 5.07 · Shareholder vote results
  • Item 9.01 · Financial statements and exhibits

More RMD filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.